| |
Featured Products
LGM Pharma is proud to present to you our new line of Monoclonal Antibodies (mAbs).
Monoclonal Antibody therapy has been proven effective in treating life threatening diseases such as cancer. Monoclonal Antibodies (mAbs) are being used earlier in the course of diseases with much success. This has sparked incredible growth in the manufacturing and supply of new mAbs, and has provided much promising news for many cancer patients.
Currently LGM Pharma supplies these cutting edge mAbs for cancer research. The following sample quantities are available for your R&D purposes:
Products Coming Soon
Currently, LGM Pharma has several new mAbs under development. Lab samples of the following mAbs will soon be available:
All of our products are available for prompt delivery. Inquiries for DMF, cGMP and all pack sizes welcome.
Call our customer support number (561) 981-9994, or contact us online at any time.
Disclaimer: Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk. |
|
|
|
Recent Blog Posts
|
|